Ex vivo exposure of bone marrow from chronic kidney disease donor rats to pravastatin limits renal damage in recipient rats with chronic kidney disease

INTRODUCTION: Healthy bone marrow cell (BMC) infusion improves renal function and limits renal injury in a model of chronic kidney disease (CKD) in rats. However, BMCs derived from rats with CKD fail to retain beneficial effects, demonstrating limited therapeutic efficacy. Statins have been reported...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stem Cell Res Ther
Main Authors: van Koppen, Arianne, Papazova, Diana A, Oosterhuis, Nynke R, Gremmels, Hendrik, Giles, Rachel H, Fledderus, Joost O, Joles, Jaap A, Verhaar, Marianne C
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4430868/
https://ncbi.nlm.nih.gov/pubmed/25889756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-015-0064-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados